Early Access — free while we kick the tires
EdgarHawk

IMNM Immunome Inc. Insider Trading

Latest: Director Bought $204K of Shares · Jun 2026
1 filing analyzed · Latest 2026-06-09
Insider buys
1
Insider sells
0
Unique insiders
1
Direction
Net buying
June 2026
2026-06-09
low
Jean Jacques Bienaime Buy
10,500 shares
$204,260
@ $19.45
Significance 4/10

Director Jean Jacques Bienaime executed 2 sales and 3 buys on same day (10.5K shares each), net neutral in share count.

On 2026-06-05, Jean Jacques Bienaime (Director) filed 2 separate sales totaling 10,500 shares for $203,820.00 alongside 3 separate purchases totaling 10,500 shares for $204,260.00 at prices ranging from $19.27 to $19.48. The transaction left his holdings unchanged at 43,415 shares while the stock currently trades at $18.39, down 33.5% from its 52-week high of $27.65. At IMNM specifically, Bienaime's 5 prior trades show mixed timing outcomes: 3 of 5 prior buys generated positive 90-day returns, while the stock has declined 18.0% over the past 30 days and 14.1% over the past 90 days. The company reported zero revenue in its latest quarter and net income of $-53,839,000.00.

Insiders here also file at

Get alerts for IMNM

Add IMNM to your watchlist and we'll email you when an insider files a Form 4 — with our AI's significance score and a plain-English read of what it means.

Sign up — free during early access